↓ Skip to main content

Steady-State Pharmacokinetics and Tolerability of Trans-Resveratrol 2000mg Twice Daily with Food, Quercetin and Alcohol (Ethanol) in Healthy Human Subjects

Overview of attention for article published in Clinical Pharmacokinetics, September 2012
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (88th percentile)
  • High Attention Score compared to outputs of the same age and source (89th percentile)

Mentioned by

blogs
1 blog
twitter
2 X users
patent
1 patent

Citations

dimensions_citation
201 Dimensions

Readers on

mendeley
152 Mendeley
Title
Steady-State Pharmacokinetics and Tolerability of Trans-Resveratrol 2000mg Twice Daily with Food, Quercetin and Alcohol (Ethanol) in Healthy Human Subjects
Published in
Clinical Pharmacokinetics, September 2012
DOI 10.2165/11531820-000000000-00000
Pubmed ID
Authors

Charles la Porte, Nha Voduc, Guijun Zhang, Isabelle Seguin, Danielle Tardiff, Neera Singhal, D. William Cameron

Abstract

Trans-resveratrol is a polyphenol, which is found in red wine and has cancer chemo-preventive properties and disease-preventive properties. The pharmacokinetics of trans-resveratrol have been investigated in single-dose studies and in studies with relatively low dosages. The present study aimed to investigate the steady-state pharmacokinetics and tolerability of trans-resveratrol 2000 mg twice daily with food, quercetin and alcohol (ethanol).

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 152 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Japan 1 <1%
Spain 1 <1%
Unknown 150 99%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 23 15%
Researcher 18 12%
Student > Master 18 12%
Student > Ph. D. Student 16 11%
Student > Doctoral Student 7 5%
Other 24 16%
Unknown 46 30%
Readers by discipline Count As %
Agricultural and Biological Sciences 24 16%
Medicine and Dentistry 23 15%
Pharmacology, Toxicology and Pharmaceutical Science 20 13%
Biochemistry, Genetics and Molecular Biology 16 11%
Nursing and Health Professions 5 3%
Other 17 11%
Unknown 47 31%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 11. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 March 2020.
All research outputs
#3,212,439
of 25,374,647 outputs
Outputs from Clinical Pharmacokinetics
#157
of 1,602 outputs
Outputs of similar age
#22,830
of 191,409 outputs
Outputs of similar age from Clinical Pharmacokinetics
#62
of 587 outputs
Altmetric has tracked 25,374,647 research outputs across all sources so far. Compared to these this one has done well and is in the 87th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,602 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.1. This one has done particularly well, scoring higher than 90% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 191,409 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 88% of its contemporaries.
We're also able to compare this research output to 587 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 89% of its contemporaries.